Author

C. A. Taylor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Organism:C. elegans· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Verge de los Aires· 1 shared B. P. Fairfax· 1 shared C. Tzeng· 1 shared E. Mahe· 1 shared H. Ruffieux· 1 shared I. Nassiri· 1 shared K. Shen· 1 shared M. R. Middleton· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Verge de los Aires

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neurons Alter Endoplasmic Reticulum Exit Sites to accommodate Dendritic Arbor Size

R. H. Land, R. D. Fetter, X. Liang, C. Tzeng, K. Shen, C. A. Taylor

This study shows that neurons adjust the number of endoplasmic reticulum exit sites (ERESs) based on dendritic arbor size in C. elegans, regulated by asymmetric cell division and nutrient sensing.

bioRxiv · Nov 3, 2022 · PreprintCell Biology

Sensitivity to Immune Checkpoint Blockade and Progression-Free Survival is associated with baseline CD8+ T cell clone size and cytotoxicity

R. A. Watson, O. Tong, R. A. Cooper, C. A. Taylor, P. K. Sharma, A. Verge de los Aires, E. Mahe, H. Ruffieux, I. Nassiri, M. R. Middleton, B. P. Fairfax

The paper uses single-cell and bulk RNA sequencing to show that CD8+ T cell subset and clone size influence gene expression responses to immune checkpoint blockade, and that pre-treatment cytotoxicity and clonality predict progression-free survival.

bioRxiv · Nov 15, 2020 · PreprintImmunology